TGA Approval

SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe (458805)

ARTG ID

458805

ARTG Name

SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe

Sponsor

Moderna Australia Pty Ltd

ARTG Date

November 15, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

MODERNA AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/a74da921e80fbb55253284d9e9ee38e1.pdf

https://medical-cdn.nocode.com/drug_tga/e2a5ef204aeb60cb44e973021d541bf5.pdf

Ingredient Name

SARS-CoV-2 JN.1 mRNA

Empowering clinical research with data-driven insights and AI-powered tools.

SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe (458805) - TGA 批准文号 | MedPath